Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174334 | SCV000225616 | likely benign | not specified | 2015-04-28 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000419683 | SCV000510575 | likely benign | not provided | 2016-11-07 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Ce |
RCV000419683 | SCV000693358 | uncertain significance | not provided | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317002 | SCV000849477 | likely benign | Inborn genetic diseases | 2017-05-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000419683 | SCV001014018 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000419683 | SCV001798787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174334 | SCV001971089 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003947471 | SCV004758519 | likely benign | ACSL4-related disorder | 2021-06-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |